-
1
المؤلفون: Rob Riemsma, Debra Fayter, Lloyd Brandts, John R. Kirwan, Kate Misso, Ben F. M. Wijnen, Nigel Armstrong, Jos Kleijnen, Charlotte Ahmadu, Sabine Grimm, Manuela A. Joore
المصدر: Pharmacoeconomics
مصطلحات موضوعية: Technology, medicine.medical_specialty, Technology Assessment, Biomedical, Filgotinib, Pyridines, Cost effectiveness, Cost-Benefit Analysis, Population, Nice, Review Article, Arthritis, Rheumatoid, Internal medicine, medicine, Adalimumab, Humans, education, TOCILIZUMAB, computer.programming_language, Pharmacology, education.field_of_study, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Triazoles, medicine.disease, Systematic review, Rheumatoid arthritis, MODIFYING ANTIRHEUMATIC DRUGS, Quality-Adjusted Life Years, business, computer, Rheumatism, medicine.drug
-
2
المؤلفون: Karolina Juraniec, Manuela Joore, Valérie D.V. Sankatsing, Harry J. de Koning, Ruud M. Pijnappel, Sabine Grimm, Nicolien T. van Ravesteyn
المساهمون: Public Health, MUMC+: KIO Kemta (9), RS: CAPHRI - R2 - Creating Value-Based Health Care, Health Services Research
المصدر: Radiology, 297(1), 40-48. Radiological Society of North America Inc.
Radiology, 297(1), 40-48. Radiological Society of North America, Inc.مصطلحات موضوعية: medicine.medical_specialty, Digital mammography, INFORMATION, Cost effectiveness, Cost-Benefit Analysis, IMAGES, STORM, Breast Neoplasms, Population based, Sensitivity and Specificity, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, Breast cancer screening, MAMMOGRAPHY, Life Expectancy, 0302 clinical medicine, SDG 3 - Good Health and Well-being, DECISIONS, Humans, Mass Screening, Medicine, Radiology, Nuclear Medicine and imaging, skin and connective tissue diseases, Early Detection of Cancer, Mass screening, Aged, OUTCOMES, medicine.diagnostic_test, business.industry, Extramural, Probabilistic logic, nutritional and metabolic diseases, WOMEN, Bayes Theorem, Digital Breast Tomosynthesis, Middle Aged, STATES, 030220 oncology & carcinogenesis, EXPECTED VALUE, Female, TRIAL, Radiology, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aa3ff54fd1474ed75c4be7e2e54b953
https://doi.org/10.1148/radiol.2020192505 -
3
المساهمون: Health Services Research, RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: Carim - B04 Clinical thrombosis and Haemostasis, MUMC+: KIO Kemta (9), Biochemie
المصدر: Value in Health, 24(7), 983-994. Elsevier Science
مصطلحات موضوعية: Technology Assessment, Biomedical, SAMPLE, INFORMATION, Computer science, Cost effectiveness, Cost-Benefit Analysis, GUIDELINES, COST-EFFECTIVENESS, EVENTS, 03 medical and health sciences, 0302 clinical medicine, Multidisciplinary approach, DECISION-ANALYTIC MODELS, STRUCTURAL UNCERTAINTY, 030212 general & internal medicine, uncertainty analysis, Risk management, Uncertainty analysis, PERFECT, business.industry, 030503 health policy & services, Health Policy, Uncertainty, Public Health, Environmental and Occupational Health, Probabilistic logic, Health technology, Expert elicitation, Economics, Medical, ASPIRIN, Risk analysis (engineering), EXPECTED VALUE, Organizational Case Studies, Feasibility Studies, Economic model, 0305 other medical science, business
-
4
المؤلفون: Jos Kleijnen, Nigel Armstrong, Gill Worthy, Bram Ramaekers, Debra Fayter, Sohan Deshpande, Xavier Pouwels, Rob Riemsma, Steven Duffy, Manuela A. Joore, Sabine Grimm, Willem J.A. Witlox
المصدر: Pharmacoeconomics
مصطلحات موضوعية: medicine.medical_specialty, Technology Assessment, Biomedical, Cost effectiveness, Cost-Benefit Analysis, Nice, Antineoplastic Agents, Review Article, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Arsenic Trioxide, Leukemia, Promyelocytic, Acute, Randomized controlled trial, Refractory, law, Internal medicine, medicine, Humans, Idarubicin, Cumulative incidence, 030212 general & internal medicine, Survival rate, Randomized Controlled Trials as Topic, computer.programming_language, Pharmacology, business.industry, 030503 health policy & services, Health Policy, Public Health, Environmental and Occupational Health, Quality-adjusted life year, Survival Rate, TRANS-RETINOIC ACID, Quality-Adjusted Life Years, 0305 other medical science, business, computer, medicine.drug
-
5
المؤلفون: Rob Riemsma, Manuela A. Joore, Xavier Pouwels, Shona H. Lang, Sabine Grimm, Nigel Armstrong, Svenja Petersohn, Lisa Stirk, Gillian Worthy, Bram Ramaekers, Janine Ross, Jos Kleijnen
المصدر: PharmacoEconomics. 37:655-667
مصطلحات موضوعية: Oncology, Urologic Neoplasms, medicine.medical_specialty, Technology Assessment, Biomedical, CARCINOMA, Cost effectiveness, Cost-Benefit Analysis, MONOTHERAPY, MULTICENTER, Nice, Antineoplastic Agents, 03 medical and health sciences, Clinical Trials, Phase II as Topic, 0302 clinical medicine, Internal medicine, SUPPORTIVE CARE, medicine, Humans, 030212 general & internal medicine, Neoplasm Metastasis, computer.programming_language, DOCETAXEL, Pharmacology, Clinical Trials, Phase I as Topic, business.industry, 030503 health policy & services, Health Policy, Hazard ratio, Public Health, Environmental and Occupational Health, PHASE-III TRIAL, OPEN-LABEL, VINFLUNINE PLUS, Gemcitabine, Quality-adjusted life year, Clinical trial, Models, Economic, Nivolumab, Docetaxel, WEEKLY PACLITAXEL, Quality-Adjusted Life Years, Urothelium, 0305 other medical science, business, computer, medicine.drug
-
6
المؤلفون: Willem J.A. Witlox, Robert Wolff, Nigel Armstrong, Jos Kleijnen, Titas Buksnys, Antoinette D I van Asselt, Annette Chalker, Gill Worthy, Lisa Stirk, Manuela A. Joore, Sabine Grimm
المصدر: Pharmacoeconomics
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Durvalumab, Lung Neoplasms, Cost effectiveness, Cost-Benefit Analysis, Nice, Antineoplastic Agents, Review Article, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, 030212 general & internal medicine, Adverse effect, computer.programming_language, Pharmacology, business.industry, 030503 health policy & services, Health Policy, Hazard ratio, Public Health, Environmental and Occupational Health, Antibodies, Monoclonal, Confidence interval, Systematic review, Quality-Adjusted Life Years, 0305 other medical science, business, computer
-
7
المؤلفون: Rob Riemsma, Gillian Worthy, Bram Ramaekers, Willem J.A. Witlox, Debra Fayter, Caro Noake, Nigel Armstrong, Jos Kleijnen, Svenja Petersohn, Xavier Pouwels, Sabine Grimm, Manuela A. Joore
المصدر: Pharmacoeconomics
مصطلحات موضوعية: medicine.medical_specialty, Technology Assessment, Biomedical, Cost effectiveness, Cost-Benefit Analysis, Population, Nice, Pembrolizumab, Review Article, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, BRENTUXIMAB VEDOTIN, DESIGN, medicine, Humans, Intensive care medicine, education, Brentuximab vedotin, computer.programming_language, Pharmacology, education.field_of_study, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Combination chemotherapy, Hodgkin Disease, Systematic review, HEALTH, Quality-Adjusted Life Years, Nivolumab, business, computer, medicine.drug
-
8
المؤلفون: Sabine Grimm, D. van der Heijde, Casper Webers, A. van Tubergen, Annelies Boonen, F. van Gaalen, Manuela A. Joore
المصدر: Annals of the Rheumatic Diseases. 79:514.1-515
مصطلحات موضوعية: medicine.medical_specialty, Cost effectiveness, business.industry, Immunology, General Biochemistry, Genetics and Molecular Biology, Quality-adjusted life year, Rheumatology, Disease severity, Family medicine, Cohort, Health care, Immunology and Allergy, Medicine, Observational study, Overdiagnosis, Axial spondyloarthritis, business
-
9
المؤلفون: Lisa Irvine, Mónica Hernández Alava, Garry Barton, Allan Wailoo, Zia Sadique, Manuel Gomes, David M. Meads, Sabine Grimm, John O’Dwyer, Stephen Pudney
المساهمون: RS: CAPHRI - R2 - Creating Value-Based Health Care, MUMC+: KIO Kemta (9)
المصدر: Value in Health, 21(1), 49-56. Elsevier Science
مصطلحات موضوعية: Male, Psychometrics, Cost effectiveness, Cost-Benefit Analysis, Health Status, Copula (linguistics), DISEASE, Arthritis, Rheumatoid, 03 medical and health sciences, 0302 clinical medicine, EQ-5D, VALUE SET, Surveys and Questionnaires, Covariate, Statistics, Econometrics, HEALTH STATES, Humans, Medicine, DRUGS, 030212 general & internal medicine, GLUCOCORTICOIDS, Cost–benefit analysis, cost effectiveness, business.industry, 030503 health policy & services, Health Policy, Public Health, Environmental and Occupational Health, Middle Aged, RANDOMIZED CONTROLLED-TRIAL, Data set, England, Cohort, Quality of Life, Female, health utility, 0305 other medical science, business, EARLY RHEUMATOID-ARTHRITIS
وصف الملف: application/pdf
-
10
المؤلفون: Simon Dixon, John Stevens, Sabine Grimm
المساهمون: RS: CAPHRI - R2 - Creating Value-Based Health Care, MUMC+: KIO Kemta (9)
المصدر: Value in Health, 21(8), 944-950. Elsevier Science
مصطلحات موضوعية: Time Factors, Computer science, Cost effectiveness, PROBABILITY-DISTRIBUTIONS, Statistics as Topic, Extrapolation, Diffusion of innovations, Value of information, COST-EFFECTIVENESS, 03 medical and health sciences, 0302 clinical medicine, Inventions, diffusion of innovations, Econometrics, IMPLEMENTATION, Humans, 030212 general & internal medicine, Diffusion (business), Expert Testimony, Parametric statistics, elicitation, cost effectiveness, business.industry, 030503 health policy & services, Health Policy, Public Health, Environmental and Occupational Health, BUDGET IMPACT ANALYSIS, FORECASTING DIFFUSION, value of information, ECONOMIC EVALUATIONS, ASSESSMENTS, New product development, PRE-LAUNCH, 0305 other medical science, Diffusion curve, business, BASS MODEL, TASK-FORCE
إعادة تعيين المنقحات
عرض المنقحات (%%عد%%)
Full Text via ClinicalKey